http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#Head http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#assertion http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#provenance http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#pubinfo http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#assertion http://purl.obolibrary.org/obo/DOID_11199 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_11199 http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB05829 http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#association http://www.w3.org/2000/01/rdf-schema#label natpara is a parathyroid hormone indicated as an adjunct to calcium and vitamin d to control hypocalcemia in patients with hypoparathyroidism limitations of use because of the potential risk of osteosarcoma natpara is recommended only for patients who cannot be well controlled on calcium supplements and active forms of vitamin d alone see warnings and precautions 5 1 natpara was not studied in patients with hypoparathyroidism caused by calcium sensing receptor mutations natpara was not studied in patients with acute post surgical hypoparathyroidism natpara is a parathyroid hormone indicated as an adjunct to calcium and vitamin d to control hypocalcemia in patients with hypoparathyroidism 1 limitations of use because of the potential risk of osteosarcoma natpara is recommended only for patients who cannot be well controlled on calcium supplements and active forms of vitamin d alone 5 1 natpara was not studied in patients with hypoparathyroidism caused by calcium sensing receptor mutations natpara was not studied in patients with acute post surgical hypoparathyroidism http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/SymptomaticReliefIndication https://identifiers.org/drugbank:DB05829 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#provenance http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#pubinfo http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#sig http://purl.org/nanopub/x/hasSignature OjEIvct5ODrMNwJHKghKR/2mt8PlSD6/Z3CTOg7eRje8iDGgIRI7dCzdB/n1K6PaSlhLdrIFxoizYTJnTPg92AN+CQYvaFvpba6Cq1WQnKGC8gaUiIjKhntp/n+yuD7E7Ttr761kItdFkdGivMKs7dn+aTbA+qMuyp0tLj5YZ0o= http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo http://purl.org/dc/terms/created 2021-07-03T14:51:17.432+02:00 http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAKkUi7Vqqjrmu2QdbFNWh9q9e9cJ4PdkoWVnfquMMuJo https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs